Erythropoietin enhances angiogenesis in an experimental cyclosporine A-induced nephrotoxicity model in the rat

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 9, 2007, Pages 866-869

  Efthimiadou, Anna ^a   Pagonopoulou, Olga ^a   Lambropoulou, Maria ^a   Papadopoulos, Nikos ^a   Nikolettos, Nikos K ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Angiogenesis; Cyclosporine A; Erythropoietin; Nephrotoxicity

Indexed keywords

ANGIOGENIC FACTOR; CYCLOSPORIN A; FIBROBLAST GROWTH FACTOR; RECOMBINANT ERYTHROPOIETIN;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GLOMERULUS CAPILLARY; HISTOLOGY; KIDNEY BLOOD VESSEL; MALE; NEPHROTOXICITY; NONHUMAN; RAT;

ANGIOGENIC PROTEINS; ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; FIBROBLAST GROWTH FACTOR 2; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34447511197     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04670.x     Document Type: Article

References (29)

1. Jelkmann W. Biology of erythropoietin. Clin. Invest. 1994 72 (Suppl. 6 S3 10.
2. Anagnostou A, Liu Z, Steiner M et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl Acad. Sci. USA 1994 91 : 3974 8.
3. Juul SE, Anderson DK, Li Y, Christensen RD. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 1998 43 : 40 9.
4. Fairchild D, Benyo D, Conrad KP. Expression of the erythropoietin receptor by trophoblast cells in the human placenta. Biol. Reprod. 1999 60 : 861 70.
5. Ribatti D, Vacca A, Roccaro AM, Crivellato E, Presta M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 2003 33 : 891 6.
6. Ribatti D, Presta M, Vacca A et al. Human erythropoietin induces a proangiogenic phenotype in cultured endothelia cells and stimulates neovascularization in vivo. Blood 1999 93 : 2627 36.
7. Kahan BD. Cyclosporine: The agent and its actions. Transplant. Proc. 1985 17 : 5 18.
8. Sulivan BA, Hak LJ, Finn WF. Cyclosporine nephrotoxicity: Studies in laboratory animals. Transplant. Proc. 1985 17 : 145 54.
9. Coffman TM, Carr DR, Yarger WE, Klotman PE. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. Transplantation 1987 43 : 282 5.
10. Moutabarrid A, Ishibashi M, Fukunaga M et al. FK506 mechanism of nephrotoxicity: Stimulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro. Transplant. Proc. 1991 23 : 3133 6.
11. Nakahama H. Stimulatory effect of cyclosporine A on endothelin secretion by a cultured renal epithelial cell line, LLC-PKI cells. Eur. J. Pharmacol. 1990 180 : 191 2.
12. Mihatsch MJ, Thiel G, Ryffel B. Morphologic diagnosis of cyclosporine nephrotoxicity. Semin. Diagn. Pathol. 1988 5 : 104 21.
13. Efthimiadou A, Lambropoulou M, Pagonopoulou O, Vakalopoulos I, Papadopoulos N, Nikolettos N. The role of basic-fibroblast growth factor (b-FGF) in cyclosporine-induced nephrotoxicity. In Vivo 2006 20 : 265 9.
14. Shihab FS, Andoh TF, Tanner AM et al. Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int. 1996 49 : 1141 51.
15. Yang CW, Ahn HJ, Kim WY et al. Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney. Kidney Int. 2001 60 : 847 57.
16. Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int. 1995 47 : 740 5.
17. Pelletier L, Regnard J, Fellmann D, Charbord P. An in vitro model for the study of human bone marrow angiogenesis: Role of hematopoietic cytokines. Lab. Invest. 2000 80 : 501 11.
18. Sharpies EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against injury and dysfunction caused by ischaemia-reperfusion. J. Am. Soc. Nephrol. 2004 15 : 2115 24.
19. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl Acad. Sci. USA 1990 87 : 5978 82.
20. Muller-Ehmsen J, Schmidt A, Krausgrill B, Schwinger RH, Bloch W. Role of erythropoietin for angiogenesis and vasculogenesis: From embryonic development through adulthood. Am. J. Physiol. Heart Circ. Physiol. 2006 290 : H331 40.
21. Galeano M, Altavilla D, Bitto A et al. Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Crit. Care Med. 2006 34 : 1139 46.
22. Westenfelder C, Biddle DL, Baranowski RL. Human, rat and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 1999 55 : 808 20.
23. Wilasrusmee C, Yusupov I, Ondocin P, Bruch D, Kittur S, Wilasrusmee S. Angiocidal effect of cyclosporin A: A new therapeutic approach for pathogenic angiogenesis. Int. Angiol. 2005 24 : 372 9.
24. Hernandez GL, Volperb OV, Iniguez MA et al. Selective inhibition of VEGF-mediated angiogenesis by cyclosporin A: Roles of the nuclear factor of activated T cells and cyclo-oxygenase 2. J. Exp. Med. 2001 193 : 607 20.
25. Lee SH, Li C, Lim SW et al. Attenuation of intersititial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Am. J. Nephrol. 2005 25 : 64 76.
26. Cancilla B, Davis A, Cauchy JA, Risbridger P, Bertam JF. FGF receptors and their ligands in the adult rat kidney. Kidney Int. 2001 60 : 147 55.
27. Floege J, Hudkins KL, Eitner F et al. Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney. Kidney Int. 1999 56 : 883 97.
28. Cauchi J, Alcorn D, Cancilla B et al. Light-microscopic immunolocalization of fibroblast growth factor-1 and -2 in adult rat kidney. Cell Tissue Res. 1996 285 : 179 87.
29. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of VEGF in renal pathophysiology. Kidney Int. 2004 65 : 2003 17.